Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular diversity

• Publication date

  2015-02-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11030-015-9569-3PMID 25652238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activities at the Universal Protein Resource (UniProt)

  2014cited by this paper
• Improvements to Robotics-Inspired Conformational Sampling in Rosetta

  2013cited by this paper
• Activities at the Universal Protein Resource (UniProt)

  2013cited by this paper
• Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

  2013cited by this paper
• Improved Docking of Polypeptides with Glide

  2013cited by this paper
• Investigation of D2 Receptor–Agonist Interactions Using a Combination of Pharmacophore and Receptor Homology Modeling

  2012cited by this paper
• Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist

  2011cited by this paper
• The Physiology, Signaling, and Pharmacology of Dopamine Receptors

  2011cited by this paper
• Strategies in the rational drug design.

  2011cited by this paper
• Crystal Structure of the β2Adrenergic Receptor-Gs protein complex

  2011cited by this paper
• Homology Modeling and Docking Evaluation of Aminergic G Protein-Coupled Receptors

  2010cited by this paper
• The impact of GPCR structures on pharmacology and structure‐based drug design

  2010cited by this paper
• Drug-like Bioactive Structures and Conformational Coverage with the LigPrep/ConfGen Suite: Comparison to Programs MOE and Catalyst

  2010cited by this paper
• A computational study on cannabinoid receptors and potent bioactive cannabinoid ligands: homology modeling, docking, de novo drug design and molecular dynamics analysis

  2010cited by this paper
• Antihypertensive Drug Valsartan in Solution and at the AT1 Receptor: Conformational Analysis, Dynamic NMR Spectroscopy, in Silico Docking, and Molecular Dynamics Simulations

  2009cited by this paper
• Receptor: Conformational Analysis, Dynamic NMR Spectroscopy, in Silico Docking, and Molecular Dynamics Simulations

  2009cited by this paper
• Structural diversity of G protein-coupled receptors and significance for drug discovery

  2008cited by this paper
• The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist

  2008cited by this paper
• Crystal structure of opsin in its G-protein-interacting conformation

  2008cited by this paper
• Comparative molecular dynamics simulations of the potent synthetic classical cannabinoid ligand AMG3 in solution and at binding site of the CB1 and CB2 receptors.

  2008cited by this paper
• Crystal structure of the ligand-free G-protein-coupled receptor opsin

  2008cited by this paper
• Structural diversity of G protein-coupled receptors and significance for drug discovery

  2008cited by this paper
• A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor.

  2008cited by this paper
• The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.

  2007cited by this paper
• G protein-coupled time travel: evolutionary aspects of GPCR research.

  2007cited by this paper
• Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity.

  2007cited by this paper
• Novel procedure for modeling ligand/receptor induced fit effects.

  2006cited by this paper
• Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

  2006cited by this paper
• How many drug targets are there?

  2006cited by this paper
• ZINC - A Free Database of Commercially Available Compounds for Virtual Screening

  2005cited by this paper
• Very fast empirical prediction and rationalization of protein pKa values

  2005cited by this paper
• A hierarchical approach to all‐atom protein loop prediction

  2004cited by this paper
• The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice.

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

  2004cited by this paper
• Protein structure prediction and analysis using the Robetta server

  2004cited by this paper
• Protein secondary structure prediction based on an improved support vector machines approach.

  2003cited by this paper
• The neurobiology of dopamine signaling

  2002cited by this paper
• The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop.

  2002cited by this paper
• The Neurobiology of Dopamine Signaling

  2001cited by this paper
• Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.

  2001cited by this paper
• Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides†

  2001cited by this paper
• Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.

  2000cited by this paper
• Effect of Multiple Serine/Alanine Mutations in the Transmembrane Spanning Region V of the D2 Dopamine Receptor on Ligand Binding

  2000cited by this paper
• The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.

  2000cited by this paper
• Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.

  1999cited by this paper
• Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT.

  1999cited by this paper
• Dopamine receptors: from structure to function.

  1998cited by this paper
• A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice.

  1998cited by this paper
• Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

  1997cited by this paper
• Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor.

  1997cited by this paper
• Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes

  1997cited by this paper
• Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice.

  1996cited by this paper
• AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR

  1996cited by this paper
• Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method.

  1995cited by this paper
• Hydrophobic Residues of the D2 Dopamine Receptor Are Important for Binding and Signal Transduction

  1995cited by this paper
• Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice.

  1995cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• Dopamine receptors: molecular biology, biochemistry and behavioural aspects.

  1994cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper
• Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.

  1993cited by this paper
• Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 Receptors

  1992cited by this paper
• Site-directed mutagenesis of the human dopamine D2 receptor.

  1992cited by this paper
• The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.

  1988cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

  1976cited by this paper
• Antipsychotic drug doses and neuroleptic/dopamine receptors

  1976cited by this paper

• Role of the weak noncovalent interactions in the stability of the aggregated protonated dopamine in the aqueous solution: spectroscopic and quantum chemical calculation studies

  2022cites this paper
• Computational and experimental approaches to probe GPCR activation and signaling.

  2022cites this paper
• Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications

  2022cites this paper
• Identification of Novel Dopamine D2 Receptor Ligands—A Combined In Silico/In Vitro Approach

  2022influential citation
• Dynamic and thermodynamic impact of L94A, W100A, and W100L mutations on the D2 dopamine receptor bound to risperidone

  2022cites this paper
• Efficiency of Homology Modeling assisted Molecular Docking in G-protein coupled receptors.

  2020cites this paper
• Preferential Coupling of Dopamine D2S and D2L Receptor Isoforms with Gi1 and Gi2 Proteins—In Silico Study

  2020cites this paper
• A Structural Analysis of the FDA Green Book-Approved Veterinary Drugs and Roles in Human Medicine.

  2020cites this paper
• Oligomerization and cooperativity in GPCRs from the perspective of the angiotensin AT1 and dopamine D2 receptors.

  2019cites this paper
• Novel Diels–Alder Type Adducts from Morus alba Root Bark Targeting Human Monoamine Oxidase and Dopaminergic Receptors for the Management of Neurodegenerative Diseases

  2019cites this paper
• A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods

  2019influential citation
• A bioinformatics approach for the understanding of membrane protein complexes

  2019cites this paper
• Metabolites of Vinca Alkaloid Vinblastine: Tubulin Binding and Activation of Nausea-Associated Receptors

  2019cites this paper
• Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2HighR and D2LowR States

  2018cites this paper
• Biochemical changes induced by grape seed extract and low level laser therapy administration during intraoral wound healing in rat liver: an experimental and in silico study

  2018cites this paper
• A QM protein–ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R)

  2018cites this paper
• Effects of vinblastine and its metabolites on nausea and alopecia associated receptors

  2018cites this paper
• Immunomodulatory Action of Substituted 1,3,4-Thiadiazines on the Course of Myocardial Infarction

  2018cites this paper
• Evaluation of the Leaf Essential Oil from Artemisia vulgaris and Its Larvicidal and Repellent Activity against Dengue Fever Vector Aedes aegypti—An Experimental and Molecular Docking Investigation

  2018cites this paper
• Investigation of chemical interactions of small peptides and vitamin substances at the developed dopamine D2 receptor models

  2017cites this paper
• Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 Receptor.

  2017cites this paper
• Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking.

  2017cites this paper
• Template selection and refinement considerations for modelling aminergic GPCR-ligand complexes.

  2017cites this paper
• The signaling pathway of dopamine D2 receptor (D2R) activation using normal mode analysis (NMA) and the construction of pharmacophore models for D2R ligands

  2017cites this paper
• Analysis of Glutamate Agonist LY 404 , 039 at Dopamine Receptor D 2 Dimeric Models Using Multiscale Molecular Modeling Approaches

  2017cites this paper
• The Signaling Pathway of Dopamine D 2 Receptor ( D 2 R ) Activation Using Normal Mode Analysis ( NMA ) and the Construction of Universal Pharmacophore Models for D 2 R Inhibitors

  2017cites this paper
• Atomistic molecular dynamics simulations of typical and atypical antipsychotic drugs at the dopamine D2 receptor (D2R) elucidates their inhibition mechanism

  2017cites this paper
• Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.

  2016cites this paper
• Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds.

  2016cites this paper
• Mutated form (G52E) of inactive diphtheria toxin CRM197: molecular simulations clearly display effect of the mutation to NAD binding

  2016cites this paper
• Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.

  2016cites this paper